Quince Therapeutics, Inc. logo

QNCX

NASDAQ

Quince Therapeutics, Inc.

Price unavailable — configure POLYGON_API_KEY

Key Statistics
Market Cap$5.51M
P/E RatioN/A
Div. Yield
EPS (TTM)-$1.20
52W High$4.55
52W Low$0.08
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees36
Price Performance
1 Week+13.01%
3 Month-96.54%
1 Year-92.14%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$167.90M
Liabilities$82.82M
Net Income$31.39M loss

About

Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases. The company is headquartered in South San Francisco, California.

WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account
Analyze QNCX with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.